Introduction Methods
Opiates acting on yi-or 6-opioid receptors increase the conductance of K+ ions resulting in hyperpolarization of the cell soma (North & Tonini, 1977; Pepper & Henderson, 1980; Werz & MacDonald, 1983; North & Williams, 1983; Mihara & North, 1986; North et al., 1988) . Opiates can also act via K-or infrequently 3-opioid receptors to decrease Ca2+ ion conductance (Macdonald & Werz, 1986; Gross & Macdonald, 1987; North et al., 1988; Bean, 1989) during nerve stimulation resulting in a decrease in transmitter release from nerve endings (Bixby & Spitzer, 1983; Lavidis, 1995a, b) . The effect of opiates on the mouse hypogastric ganglia ) and mesenteric ganglia (Bornstein & Fields, 1983) has been studied by use of intracellular recordings of the excitatory postsynaptic potentials (e.p.s.ps) and miniature excitatory postsynaptic potentials (m.e.p.s.ps). In both studies quantal analysis of e.p.s.ps and m.e.p.s.ps suggested that opiates were decreasing quantal release by a presynaptic mechanism. This may occur either by opiates hindering propagation of the nerve bouton impulses (NBI) along the preganglionic axons or by impairing coupling of the NBI to transmitter release possibly by inactivating the voltage sensitive calcium channels.
The rat pelvic ganglia was chosen for this study because the postganglionic cell bodies are large (15-30 pm) and have no dendritic arborisation of their spherical or ovoid shapes (Tabatabai et al., 1986; Snider, 1987; Purves et al., 1988) . Each cell is innervated by a single preganglionic axon which forms short strings or clusters of boutons de Groat & Booth, 1993) . Locating boutons with an extracellular microelectrode was made easy by DiOC2(5)-fluorescence following careful removal of the capsule and other material covering the ganglia. Large diameter tip electrodes could then be used to record the NBI, e.p.s.c. and the postsynaptic action potential (AP). In this study we have investigated the effects of opiates on neurotransmission between preganglionic nerve fibres of the hypogastric nerve and the postganglionic cell bodies.
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Preparation of tissues
Rats (AAW) aged between 5 and 7 weeks postnatal were anaesthetized with ether and killed by cervical fracture. Both pelvic ganglia were dissected free from the surrounding tissues. Each ganglion was pinned on the bottom of a 3 ml capacity bath on a thin layer of Sylgard (Dow Corning). The preparation was continuously perfused at the rate of3 ml per min with a modified Tyrode solution ofthe following composition (mM): NaCl 123.4, KCl 4.7, MgCl2 1.0, NaH2PO4 1.3, NaHCO3 16.3, CaCl2 0.2-1.0, glucose 7.8. The temperature of the bath was maintained between 32°C and 34°C. The reservoir supplying the bath was continuously gassed with 95% 02 and 5% CO2 maintaining the pH at 7.3. The extracellular calcium concentration ([Ca2+] .) was changed by altering the amount ofCaCl2 dissolved in the Tyrode solution supplying the bath.
Stimulation
The hypogastric nerve was gently sucked into a pipette filled with modified Tyrode solution. A silver/silver chloride wire on the inside of the pipette and one on the outside were used to stimulate the hypogastric nerve with square wave pulses of 0.05 ms duration and 10 to 17 V amplitude. The axons were stimulated continually at 0.1 Hz while searching for the extracellular signs of the NBI and the e.p.s.c. produced by released transmitter activating the postsynaptic receptors.
Visualization of the hypogastric boutons
The preparation was initially bathed in Tyrode solution containing 2 mM [Ca2+]0 for about 20 min. It was then bathed for 30 s in 3-3 diethyloxardicarbocyanine iodide (0.1 ,M; DiOC2(5); Yoshikami & Okun, 1984; Lavidis & Bennett, 1992; and then washed with modified Tyrode solution for 3 min. Boutons were chosen by viewing the DiOC2(5)-fluorescent image via a 50 times long working distance air objective. An image intensifier camera (Panasonic) attached to an Olympus (BH2) microscope equipped with rhodamine filter set was used to display the image on a video monitor (National).
Brftish Journal of Pharmacology (1996) 118, 1913-1918 The effects of exposing neurones and terminals to DiOC2(5)-fluorescence have been described previously (Lavidis & Bennett, 1992) . The arrangement of DiOC2 (5) (5), (10 mM) dissolved in dimethylsulphoxide (DMSO) were kept refrigerated for up to 6 weeks. From this stock solution 0.1 ml was serially diluted to 10 gm in distilled H20. The solution of DiOC2(5) was finally diluted to 0.1 gM in Tyrode solution.
Results
Recording of NBI and e.p.s.c. from visualized hypogastric boutons DiOC2(5)-fluorescence was used to visualize the surface hypogastric boutons innervating the ganglion cells (Figure 1 ). These structures were about 1 pm in diameter and were fluorescing brightly on the surface of the ganglion cells. The extracellular signs of the NBI were recorded with electrodes having tip diameters between 5 and 10 gm (Figure 2 ). The NBI amplitude varied considerably between preparations but did not vary during the period of recording from single boutons or small group of 2 to 4 boutons. In all recordings the amplitude of the NBI could not be graded when the stimulation voltage was altered; this all or none behaviour of the NBI was taken to mean that we were recording from a single axon.
Effect of opioid receptor agonists on the pre-ganglionic
NBI
The effect of opiates on the amplitude, time course and consistency of the NBI was evaluated. Neither the mean amplitude of the NBI nor its variance were affected by U50488H ( Figure  3 ). The variance in NBI amplitude of control and U50488H-treated preparations shown in Figure 3 was similar to the variance in electrical noise during the recording indicating that the amplitude of the NBI is invariant. Morphine (10 gM), dynorphin-A (4 gM) and U50488H (1 gM) did not alter the consistency with which the NBI was recorded over 200 nerve impulses. There was no significant (P<0.05) difference in the amplitude of the NBI (Figure 3c and 4) following treatment of the preparations with morphine (10 Mm, n=7) dynorphin-A (4 gM, n = 4) or U50488H (1 pM, n = 9). Naloxone (10 gM) was administered after each treatment and showed no significant change in the amplitude of the NBI (Figure 4 ).
Effect of opiates on the e.p.s.cs
Extracellularly positioned electrodes over single or small groups of boutons (Figure 1) recorded the NBI and extracellular signs of the e.p.s.c. generated when transmitter released from the bouton activated postsynaptic receptors on the ganglion cell (Figure 2 ). If these e.p.s.cs were of significant amplitude a postsynaptic action potential was generated on the recovery phase of the e.p.s.cs (Figure 2 , control traces 1, 4, 5 and 7). These postganglionic action potentials could be reduced in frequency or abolished by decreasing the extracellular calcium concentration ([Ca2+] U50488H as shown in Figure 2 . Although the average amplitude of the e.p.s.cs decreased in all preparations studied when U50488H was administered, the maximum amplitude of e.p.s.cs did not change significantly. Thus the reduced frequency of postsynaptic action potentials induced by U50488 occurred as a result of a decrease in the frequency of quantal release rather than a decrease in quantal size (i.e. mean quantal size+ s.e.mean for controls was 34 + 4 yV (n = 100) and for U50488H was 35 + 4 pV (n = 100), Figure 5 ) favouring a presynaptic mode of action for the drug.
The effect of morphine (10 pM), dynorphin-A (4 gM) and U50488H (1 pM) on the average normalised e.p.s.c. amplitude was evaluated (Figure 6 ). Morphine up to 10 pM did not affect the amplitude of e.p.s.cs (n=7). Application of naloxone (10 pM) to morphine-treated preparations slightly increased the amplitude of e.p.s.cs but this was not significant. Dynorphin-A (4 pM) decreased the amplitude of e.p.s.cs by 32+ 19% (mean + s.e.mean, n = 4, P< 0.1). Naloxone (10 pM) abolished this decrease and again the e.p.s.c. amplitudes were slightly greater than for controls but this increase was not significant. U50488H (1 pM) significantly (P<0.05) decreased the amplitude of e.p.s.cs by 54+12% (n=9) when compared to controls. Naloxone (10 pM) abolished this decrease and again the e.p.s.c. amplitudes were slightly greater than for controls but this increase was not significant (Figure 6 ). The decrease in average e.p.s.c. amplitude observed when dynorphin-A (4 pM) and U50488H (1 gM) was administered to the rat pelvic ganglia was predominantly due to an increase in the number of failures to evoke e.p.s.cs during nerve stimulation ( Figure 7 ). U50488H (1 pM) was the most effective inhibitor of evoked transmitter release since it was able to increase the number of failures by 2.8 + 0.7 times when compared to controls, dynorphin-A (4 pM) increased the failure rate by 2.1 + 0.6 times when compared to controls while morphine (10 pM) had no effect on the failure rate ( Figure 7 ).
Discussion
Visualisation and recording from the hypogastric boutons
The large ovoid ganglion cells of the rat pelvic ganglia are innervated by single axons arising from the hypogastric nerve (Tabatabai et al., 1986; Snider, 1987; Purves et al., 1988; . The boutons innervating these large ganglion cells are about 1 pm in diameter and about 30% of the bou- Normalized number of failures Figure 7 The effect of opiates on the rate of failures in quantal release from hypogastric boutons during nerve stimulation at 0. (Henderson et al., 1972; Bennett & Lavidis, 1980; Illes et al., 1980; Lavidis, 1995c ) mesenteric neurones (Bornstein & Fields, 1983) ; amphibian neuromuscular junction (Frederickson & Pinsky, 1970; Bixby & Spitzer, 1984; Lavidis, 1995a, b) and the mouse hypogastric ganglia . In all these preparations opiates have been clearly shown to act presynaptically to induce a decrease in quantal release rather than affecting quantal size. demonstrated a presynaptic locus of action for opiates at the mouse hypogastric ganglia using intracellular recordings of e.p.s.ps and quantal analysis. We have used a more direct approach to investigate the presynaptic locus of action for the opiates using loose patch recording with an extracellular electrode to record the NBI, e.p.s.cs and postsynaptic action potential simultaneously. The present study confirms the presynaptic locus of action of opiates by showing that opiates increase the number of failures to evoke e.p.s.cs without affecting the mean size of e.p.s.cs during low frequency stimulation (0.1 Hz) of the hypogastric nerve. The mean amplitude, time course or consistency with which the NBI was recorded were not affected by any of the opiates tested.
Which opioid receptor is responsible for the decrease in transmitter release?
Morphine is known to be a good y-opioid receptor agonist and a poor 6-and K-opioid receptor agonist (Robson et al., 1983) . Dynorphin-A and U50488H are known to be fairly specific Kopioid receptor agonists (Chavkin et al., 1982) . In this study morphine was shown not to affect quantal release while dynorphin-A and U50488H decreased quantal release. These results suggest that K-opioid receptors are located presynaptically on the boutons of the hypogastric nerve. Activation of these K-opioid receptors results in a decrease in quantal release without any affect on the propagation or the time course of the NBI. This inhibitory effect of K-opioid receptor agonists was completely abolished by administration of naloxone or by increasing the [Ca21] . from 0.3 to 1.0 mM. Similar antagonism of the opiate-induced inhibition of quantal secretion by increasing [Ca2+] o has been demonstrated in the mouse vas deferens (Bennett & Lavidis, 1980; Illes et al., 1980; Einstein & Lavidis, 1984; Lavidis, 1995c) , the amphibian neuromuscular junction (Lavidis, 1995a, b) and the hypogastric ganglia of mouse .
In conclusion, the boutons of the hypogastric nerve innervating the rat pelvic ganglion cells seem to possess K-opioid receptors. When these receptors are activated by dynorphin-A or U50488H there was a decrease in the release of quanta without any effect on the propagation of the NBI. This decrease in quantal release was counteracted by increasing
[Ca21]0, suggesting that the opiate-induced decrease involves an action on the entry of [Ca2+]0 during nerve stimulation.
